Weight loss can be a challenge, even for those who eat healthily and exercise regularly. But injectable type 2 diabetes ...

Liraglutide injection, 18 mg/3 ml (6 mg/ml) single-patient-use prefilled pen (RLD Victoza) had a market value of roughly $458 million, per IQVIA May 2025 data.

Lucknow: In a new trend, people with obesity are using injections originally prescribed for diabetics to lose weight.Doctors ...

The dosage range of liraglutide is 0.6mg to 3mg, taken once daily as a subcutaneous injection. The dosage range of tirzepatide is 2.5mg to 15mg, taken once weekly as a subcutaneous injection.

Saxenda (liraglutide) is a GLP-1 agonist injection pen medication. It helps with sustained weight loss for adults with obesity, adults with overweight who are experiencing weight-related health ...

“By launching an authorized generic for Victoza ® (liraglutide injection 1.8 mg), we are providing patients with type 2 diabetes another option for this important treatment,” said Ernie ...

Global pharma major Lupin Limited (Lupin) announced that it has received approval from the United States Food and Drug Administration (FDA) for its Abbreviated New Drug Applications for liraglutide ...

Both semaglutide and liraglutide injections showed improvements not only in diabetes control (they reduce the A1C test, a marker for blood sugar, by 1 to 1.5 percentage points), but in death due ...

This generic GLP-1 is liraglutide for injection (the generic version of Victoza). It differs from Wegovy because its active ingredient is liraglutide, not semaglutide.

Lupin receives USFDA approval for generic diabetes medications, including Liraglutide Injection and Glucagon for Injection.